+ All Categories
Home > Documents > PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING...

PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING...

Date post: 15-Oct-2020
Category:
Upload: others
View: 0 times
Download: 0 times
Share this document with a friend
14
PROGRAM AMERICANPSYCHIATRICASSOCIATION Philadelphia,PA∎May18-23,2002
Transcript
Page 1: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

PROGRAMAMERICAN PSYCHIATRIC ASSOCIATION

Philadelphia, PA ∎ May 18-23, 2002

Page 2: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

AMERICAN PSYCHIATRIC ASSOCIATIONCONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE

The American Psychiatric Association requires disclosure by presenters at CME activities of any significant financial or other affiliationwith commercial goods/organization(s) that may have a direct or indirect interest in the subject matter of the scientific program . A"financial interest" may include, but is not limited to, being a shareholder in the organization ; being on retainer with the organization ; orhaving research or honoraria paid by the organization. An "affiliation" may include holding a position on an advisory committee or someother role or benefit to a supporting organization . The existence of such relationships does not necessarily constitute a conflict of interest,but the prospective audience must be informed of the presenter's affiliation with every commercial supporter by an acknowledgement inthe printed program and oral or visual disclosure to participants at the session (disclosure by slide or overhead is required if audiovisualequipment is used for the presentation) . This policy is intended to openly identify any potential conflict(s) so that members of the audiencein an educational activity are able to form their own judgments about the presentation . The APA also requires oral disclosure of discussionof unapproved uses of a commercial product or investigational use of a product not yet approved for this purpose .

The following presenters have indicated a significant financial interest or other affiliation with a commercial supporter of thesession and/or with the manufacturer(s) of a commercial product(s) and/or provider of commercial service(s) . The presenter'sname, the manufacturer's name, and the page number(s) the presenter appears on in this Program Book are listed below :

Presenter Manufacturer(s) Program Page #

Gene G. Abel, M.D . Abel Screening, Inc. 67Lenard A. Adler, M .D . Eli Lilly and Company ; Alza Pharmaceuticals ; G1axoSmithKline 3Hagop S. Akiskal, MD . Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a

division of Eli Lilly and Company ; Abbott Laboratories 33,56George S . Alexopoulos, M.D. Forest Laboratories, Inc . ; National Institute of Mental Health ; Lilly Research Laboratories, a

division of Eli T .illyand Company; Pfizer Inc. ; GlaxoSmithKline ;AstraZeneca Pharmaceuticals; Janssen Phanmaceutica and Research Foundation 5,30

Albert J. Allen, M.D. Eli Lilly and Company (employer) 3Anne Alonso, Ph.D. Eli Tally and Company 6Jonathan E . Alpert, M.D . Abbott Laboratories ; Bristol-Myers Squibb; Cyberonics ; Eli T illy and Company;

GlaxoSmithKline ; Lichtwer Pharma; Novartis Pharmaceuticals Corporation ; Organon Inc. ;Pfizer Inc . ; Pharmacia Corporation; Roche Laboratories, a member of the Roche Group;Sanofi Pharmaceuticals, Inc. ; Solvay Pharmaceuticals, Inc. ; Synthelabo ; WyethPharmaceuticals 61

Jay D. Amsterdam, M .D . Eli T illy and Company; Somerset Pharmaceuticals, Inc. ; Pfizer Inc.;Organon Inc . ; Forest Laboratories, Inc.; Merck & Co ., Inc. ; Wyeth Pharmaceuticals;GlaxoSmithKline; Biophann; Organon Inc. 96

Jose C. Appolinario, M.D. Knoll Pharmaceutical Company 32Ralph Aquila, M.D. Eli Lilly and Company 6Kimberly A. Arlinghaus, M.D . Pfizer Inc.; Lilly Research Laboratories, a division of Eli Lilly and

Company; Forest Laboratories, Inc . ; Wyeth Pharmaceuticals; Janssen Pharmaceutica andResearch Foundation; Bristol-Myers Squibb ; AstraZeneca Pharmaceuticals; Abbott Laboratories ;Cephalon, Inc. 5

Jorge L. Armenteros, M.D. Janssen Pharmaceutica and Research Foundation 63Peter M. Aupperle, M.D . Pfizer Inc.; Novartis Pharmaceuticals Corporation ; Janssen Pharmaceutica

and Research Foundation 7Robert W. Baker, M.D. Eli Lilly and Company 24,75Benjamin H. K. Balderson, Ph.D. Group Health Cooperative (employer) 59Richard Balon, M .D. Bristol-Myers Squibb; GlaxoSmithKline; Pfizer Inc. ; Novartis Pharmaceuticals

Corporation; T ,lly Research Laboratories, a division of Eli Lilly and Company ;Forest Laboratories, Inc.; Parke-Davis, Division of Warner-Lambert Company;Organon Inc. ; Solvay Pharmaceuticals, Inc.; Wyeth Pharmaceuticals; Merck & Co., Inc . 97

Paul J. Barreira, M .D. Eli Lilly and Company 6Gail M. Barton, M.D . Wyeth Pharmaceuticals 19Mark S . Bauer, M.D . Novartis Pharmaceuticals Corporation; GlaxoSmithKline ; Solvay Pharmaceuticals, Inc . 59Philip M. Becker, M .D . Cephalon, Inc. 49Bernard D . Beitman, M .D . Pfizer Inc. ; GlaxoSmithKline 8,29Ruth M. Benca, M .D . Wyeth Pharmaceuticals ; Cephalon, Inc .; Sanofi Pharmaceuticals, Inc.; National Institute

of Mental Health; Merck & Co., Inc. ; Sepracor, Inc. 85Joseph Biederman, M.D . Shire U.S., Inc. ; Gliatec, Inc. ; Cephalon, Inc.; GlaxoSmithKline ; Eli T .illy and

Company; Alza Pharmaceuticals ; Pfizer Inc. ; Wyeth Pharmaceuticals 86Bradley F. Boeve, M .D. Pfizer Inc . ; Eisai Inc. 86Howard E. Book, M.D . American Psychiatric Press Inc . 27,50Soo Borson, M.D. Janssen Pharmaceutica and Research Foundation; Pfizer Inc . ; Forest Laboratories, Inc. ;

Wyeth Pharmaceuticals 63

Page 3: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

Presenter

Charles L. Bowden, M.D.

Kathleen T . Brady, M.D .

George Brainard, Ph .D.Olga Brawman-Mintzer, M.D .

Alan F . Breier, M.D.William Breitbart, M .D.

Lawrence Brown, M.D .Thomas E. Brown, Ph.D.

Peter F. Buckley, M.D .

Kathryn A . Bums, M.D .George Bush, M.D.Ira R. Byock, M.D .Joseph R. Calabrese, M .D .

Lori Calabrese, M.D.

Joshua W. Calhoun, M .D .

Linda L . Carpenter, M .D .

Diana Carter, M.B .William P. Carter, M .D .Daniel E . Casey, M.D .

David Castle, M .D .Patrizia A. Cavazzoni, M .D .Carlyle H. Chan, M .D .Kiki D . Chang, M.D .Kyong-Mi Chang, M .D .Dennis S . Charney, M .D .

Josepha A. Cheong, M.D .James C .Y. ChouLeslie L . Citrome, M.D .

Anita H . Clayton, M .D.

Judith A. Cohen, M .D.Lee S. Cohen, M.D .

Manufacturer(s) Program Page #

Abbott Laboratories ; AstraZeneca Pharmaceuticals ; Bristol-Myers Squibb ; GlaxoSmithKline;Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division ofEli Lilly and Company; National Institute of Mental Health; Parke-Davis, Division ofWarner-Lambert Company; Pfizer Inc . ; R.W. Johnson Pharmaceutical Institute ;Sanofi Pharmaceuticals, Inc . ; Stanley Foundation; UCB Pharma, Inc .

8,11Pfizer Inc . ; Abbott Laboratories; Lilly Research Laboratories, a division of Eli Lilly andCompany; GlaxoSmithKline ; Bristol-Myers Squibb

37, 55, 87Bio-Brite, Inc; Philips

8AstraZeneca Pharmaceuticals; Eli Lilly and Company; Pfizer Inc. ; JanssenPharmaceutica and Research Foundation

87Eli Lilly and Company

95Janssen Pharmaceutica and Research Foundation ; Johnson and Johnson, Ortho-Biotech ; Bristol-Myers Squibb ; Eli Lilly and Company

29GlaxoSmithKlne; AGVRON

44Aiza Pharmaceuticals; American Psychiatric Press Inc . ; Cephalon, Inc .; Eli Lilly and Company ;GlaxoSmithKline; Novartis Pharmaceuticals Corporation ; Pfizer Inc . ; ShireU.S ., Inc .; The Psychological Corporation ; Yale University Press

1, 3, 78AstraZeneca Pharmaceuticals; Eli Lilly and Company; Janssen Pharmaceutica andResearch Foundation ; Novartis Pharmaceuticals Corporation

86,96Eli Lilly and Company

G9Pfizer Inc. ; Eli Lilly and Company ; Shire U.S ., Inc .

86Purdue; Pfizer Inc .; Janssen Pharmaceutica and Research Foundation ; Knoll

70National Institute of Mental Health; Abbott Laboratories; Ciba Geigy Corporation,Pharmaceutical Division; Merck & Co., Inc .; Forest Laboratories, Inc . ; GlaxoSmithKline ; LillyResearch Laboratories, a division of Eli Lilly and Company; MacArthur Foundation; NationalAlliance for Research in Schizophrenia and Affective Disorders ; Parke-Davis, Division ofWarner-Lambert Company ; Robert Wood Johnson Pharmaceutical Research Institute ; SandozPharmaceuticals Corporation ; Stanley Foundation ; TAP Pharmaceuticals; UCB Pharma; WyethPharmaceuticals; AstraZeneca Pharmaceuticals; Elan Pharmaceuticals ; Eli Lilly and Company ;Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation ;Shire U.S ., Inc . ; Teva Pharmaceuticals

3, 5, 63GlaxoSmithKline; Lilly Research Laboratories, a division of Eli Lilly and Company; WyethPharmaceuticals ; Pfizer Inc .; Abbott Laboratories; Bristol-Myers Squibb

37Novartis Pharmaceuticals Corporation; Eli Lilly and Company ; Bristol-Myers Squibb; OrganonInc. ; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation ; AstraZenecaPharmaceuticals

80Corcept; Pfizer Inc.; Forest Laboratories, Inc . ; Merck & Co., Inc . ; Cyberonics; Organon Inc. ;Abbott Laboratories; Parke-Davis, Division of Warner-Lambert Company ; GlaxoSmithKline

6, 11, 52GlaxoSmithKline

8Eli Lilly and Company; Wyeth Pharmaceuticals ; Ortho-McNeil Pharmaceuticals

86Abbott Laboratories; AstraZeneca Pharmaceuticals ; Lilly Research Laboratories, a division ofEli Lilly and Company; Novartis Pharmaceuticals Corporation ; Pfizer Inc. ; Janssen Pharmaceuticaand Research Foundation

64,65Eli Lilly and Company

55Eli Lilly and Company (employer)

47Medscape

38,52Abbott Laboratories ; Eli Lilly and Company; Solvay Pharmaceuticals, Inc .

5Wyeth Pharmaceuticals ; Vivopharma

44AstraZeneca Pharmaceuticals; Abbott Laboratories; Bristol-Myers Squibb ; Cyberonics ; DovPharmaceuticals; Eli Lilly and Company; Forest Laboratories, Inc . ; Infoscriber ; JanssenPharmaceutica and Research Foundation ; Merck & Co ., Inc . ; Mindsense; Mitsubishi Chemical ;Novartis Pharmaceuticals Corporation; Organon Inc. ; Pfizer Inc . ; Pharmacia Corporation ;R.W. Johnson Pharmaceutical Research Institute ; Sepracor, Inc . ; Skila; GlaxoSmithKline; SomersetPharmaceuticals, Inc. ; Solvay Pharmaceuticals, Inc .; Velva Pharmaceuticals

34,97Janssen Pharmaceutica and Research Foundation ; Pfizer Inc. ; Wyeth Pharmaceuticals

25,51Pass the Boards, Inc.

15Novartis Pharmaceuticals Corporation ; Lilly Research Laboratories, a division of Eli Lilly andCompany; Janssen Pharmaceutica and Research Foundation ; AstraZeneca Pharmaceuticals;Abbott Laboratories ; Pfizer Inc .

30Corcept; Forest Laboratories, Inc . ; GlaxoSmithKline ; Organon Inc.; Pfizer Inc. ; PharmaciaCorporation; Eli Lilly and Company; Bristol-Myers Squibb ; Organon, Inc .

65Pfizer Inc.

71, 94, 95Forest Laboratories, Inc. ; Janssen Pharmaceutica and Research Foundation ; Eli Lilly andCompany; Organon Inc.; Pfizer Inc. ; GlaxoSmithKline; Wyeth Pharmaceuticals; SolvayPharmaceuticals, Inc.

11, 23, 57

XIX

Page 4: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

Presenter

Steven A . Cole, M.D .Robert R. Conley, M.D.

Kathryn M . Connor, M.D .Barbara Comblatt, Ph.D .Paul T. Costa, Jr., Ph .D.Andrew J. Cutler, M.D.

Daniella David, M .D .Jonathan R.T. Davidson, M.D .

Jonathan S . Davine, M.D.

Kenneth L . Davis, M .D.

Denise De Guzman, M.D .Deborah Deas, M.D .Pedro L. Delgado, M.D .

Davangere P. Devanand, M.D.C. Lindsay DeVane, Pharm .D .

Mantosh J . Dewan, M.D .

David F. Dinges, Ph.D .Karl Doghramji, M.D .Rachelle S . Doody, M .D .

P. Murali Doraiswamy, M.D.

Robert T. Dunn, M.D .David L. Dunner, M.D .

Steven A. Epstein, M .D .Milton K. Erman, M .D .

Javier I . Escobar, M.D.Raymond A. Faber, M.D .Stephen V . Faraone, Ph.D.

Martin K Farlow, M.D .Maurizio Fava, M.D .

Jan A . Fawcett, M .D.

Joel S. Feiner, M.D.

xx

Manufacturer(s)

Program Page #

Eli Lilly and Company; Pfizer Inc.

60AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation; IVAXPharmaceuticals; Novartis Pharmaceuticals Corporation ; Eli Lilly and Company

63,96Pfizer Inc. ; Eli Lilly and Company; PureWorld Botanicals ; Ancile Pharmaceuticals; GlaxoSmithKline

8Otsuka Pharmaceuticals ; Janssen Pharmaceutica and Research Foundation

65,87Neo Five-Factor Inventory

82Abbott Laboratories ; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb; JanssenPharmaceutica and Research Foundation; Lilly Research Laboratories, a division of Eli Lillyand Company; Pfizer Inc. ; Novartis Pharmaceuticals Corporation ; Forest Laboratories, Inc . ;Shire U.S., Inc. ; Otsuka Pharmaceuticals; Sumitomo; Wyeth Pharmaceuticals ; GlaxoSmithKline

6Janssen Pharmaceutica and Research Foundation

55Pfizer Inc. ; American Home Products; GlaxoSmithKline ; Proctor and Gamble ; TrianglePharmaceuticals; Solvay Pharmaceuticals, Inc .; Forest Laboratories, Inc . ; Eli Lilly and Company;Ancile ; Roche Laboratories, a member of the Roche Group; Novartis Pharmaceuticals Corporation ;Wyeth Pharmaceuticals; Organon Inc . ; PureWorld; Schwabe; MultiHealth Systems, Inc ., GuilfordPublications ; American Psychiatric Association

8,64Solvay Pharmaceuticals, Inc . ; GlaxoSmithKline; Pfizer Inc . ; Lundbeck; Janssen Pharmaceutica andResearch Foundation; AstraZeneca Pharmaceuticals; Eli Lilly and Company; Wyeth Pharmaceuticals

71Janssen Pharmaceutica and Research Foundation ; Lilly Research Laboratories, a division of Eli Lillyand Company; Abbott Laboratories; Mitsubishi; Scirex

12Pharmacia Corporation

77Bristol-Myers Squibb ; Pfizer Inc.

58National Institute of Mental Health; Bristol-Myers Squibb ; Eli Lilly and Company ; GlaxoSmithKline;Organon Inc. ; Otsuka Pharmaceuticals; Pharmacia Corporation; Solvay Pharmaceuticals, Inc .; WyethPharmaceuticals ; Janssen Pharmaceutica and Research Foundation; Boehringer Ingelheim; ForestLaboratories, Inc .; Parke-Davis, Division of Warner-Lambert Company ; Pfizer Inc. ; NovartisPharmaceuticals Corporation; AstraZeneca Pharmaceuticals

64Pfizer Inc. ; Eli Lilly and Company; Wyeth Pharmaceuticals; Pfizer Inc.

30Eli Lilly and Company; Wyeth Pharmaceuticals ; AstraZeneca Pharmaceuticals ; GlaxoSmithKline;Janssen Pharmaceutica and Research Foundation ; Bristol-Myers Squibb; Forest Laboratories, Inc .

2Pfizer Inc. ; Lilly Research Laboratories, a division of Eli Lilly and Company ; Janssen Pharmaceuticaand Research Foundation

38Cephalon, Inc.

86Sanofi Pharmaceuticals, Inc. ; Eli Lilly and Company; Wyeth Pharmaceuticals ; Cephalon, Inc .

13, 23, 27, 86Eisai Inc . ; Pfizer Inc. ; Janssen Pharmaceutica and Research Foundation ; Merz ; ForestLaboratories, Inc .; Fujisawa; Elan Pharmaceuticals

85Eisai Inc .; Pfizer Inc. ; Novartis Pharmaceuticals Corporation ; Janssen Pharmaceutica andResearch Foundation; GlaxoSmithKline ; Elan Pharmaceuticals ; Wyeth Pharmaceuticals; LillyResearch Laboratories, a division of Eli Lilly and Company ; Merck & Co ., Inc .; NationalInstitutes of Health ; Forest Laboratories, Inc . ; Lundbeck

64Novartis Pharmaceuticals Corporation

90Eli Lilly and Company; Pfizer Inc. ; GlaxoSmithKline; Wyeth Pharmaceuticals ; Bristol-MyersSquibb; Forest Laboratories, Inc . ; Mitsubishi ; Cyberonics; Pharmacia Corporation; OrganonInc.

13, 33, 37, 47Pfizer Inc. ; AstraZeneca Pharmaceuticals

49Searle; Pharmacia Corporation; Wyeth Pharmaceuticals ; Pfizer Inc .; Takeda Pharmaceuticals ;Neurocrine Diosciences; Orphan Medical; Sepracor, Inc . ; Resmed Sanofi Pharmaceuticals,Inc., Cephalon, Inc . ; Forest Laboratories, Inc .

13,37Pfizer Inc. ; Bristol-Myers Squibb; Wyeth Pharmaceuticals; Johnson and Johnson

1Janssen Pharmaceutica and Research Foundation ; Pfizer Inc .

1,5Alza Pharmaceuticals ; Shire U.S ., Inc .; Wyeth Pharmaceuticals; Janssen Pharmaceutica andResearch Foundation; Eli Lilly and Company; GlaxoSmithKline; SG Cowan

86Novartis Pharmaceuticals Corporation

64Eli Lilly and Company; G1axoSmithKline ; Pfizer Inc . ; Wyeth Pharmaceuticals ; Organon Inc .;Bristol-Myers Squibb ; Pharmacia Corporation ; Solvay Pharmaceuticals, Inc . ; Forest Laboratories, Inc .;Sanofi Pharmaceuticals, Inc. ; Janssen Pharmaceutica and Research Foundation; Lundbeck; KnollPharmaceuticals ; Parke-Davis, Division of Warner-Lambert Company ; Somerset Pharmaceuticals, Inc . ;Pharmavite; Abbott Laboratories ; Roche Laboratories, a member of the Roche Group; NovartisPharmaceuticals Corporation; Lorex Pharmaceuticals ; Lichtwer PharmaNational Institute of Mental Health; Abbott Laboratories; Bristol-Myers Squibb;G1axoSmithKline ; Eli Lilly and Company; Pfizer Inc . ; Theodore and Vada Stanley Foundation ;Wyeth Pharmaceuticals ; Forest Laboratories, Inc . ; Merck & Co ., Inc. ; Parke-Davis, Division ofWarner-Lambert Company; Pharmacia Corporation ; Solvay Pharmaceuticals, Inc .Eli Lilly and Company; Telecare

6, 13

29, 9632

Page 5: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Stephen J. Ferrando, M.D . Merck & Co ., Inc. ; Pfizer Inc . 29,61Howard Fillit, M.D . Pfizer Inc. ; Novartis Pharmaceuticals Corporation 92Robert L. Findling, M.D . Abbott Laboratories; Solvay Pharmaceuticals, Inc . ; Janssen Pharmaceutica and Research

Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company ; AstraZenecaPharmaceuticals; Bristol-Myers Squibb; Pfizer Inc.; Somerset Pharmaceuticals, Inc .; Shire U.S ., Inc. ;

GlaxoSmithKline; Wyeth Pharmaceuticals ; Organon Inc. ; Forest Laboratories, Inc . 5, 14, 38

Mara J. Fiorentino, M .D . Eli Lilly and Company 71

Kathleen M. Fisher, Ph.D. Pfizer Inc . ; Organon Inc. ; Novartis Pharmaceuticals Corporation ; Lilly Research Laboratories,a division of Eli Lilly and Company; AstraZeneca Pharmaceuticals; Janssen Pharmaceuticaand Research Foundation ; Wyeth Pharmaceuticals ; Manor Health Care ; Abbott Laboratories;Bristol-Myers Squibb; Organon Inc. 80

Marc Fishman, M.D. Potomac Healthcare Foundation ; Mortain Manor Treatment Center 84

Lois T . Flaherty, M.D . Merck & Co., Inc. ; Pfizer Inc . 39,89

Lyle B . Forehand, Jr., M.D . GlaxoSmithKline 25

Richard J . Frances, M.D . Abbott Laboratories; Forest Laboratories, Inc . ; Schering Plough; Merck & Co., Inc. ; Organon Inc. ;Pfizer Inc.; Pharmacia Corporation; Suburban Hill Hospital 44

Ellen Frank, Ph .D . Pfizer Inc .; Forest Laboratories, Inc . ; Eli Lilly and Company; NationalInstitute of Mental Health 3,13, 96

W. Gordon Frankle, M .D . Janssen Pharmaceutica and Research Foundation; AstraZeneca Pharmaceuticals 8

Jean A. Frazier, M .D . Eli Lilly and Company 6Robert Freedman, M .D . AstraZeneca Pharmaceuticals 12Matthew J. Friedman, M .D . Pfizer Inc. ; GlaxoSmithKline 71

Mark A . Frye, M .D . Abbott Laboratories; Eli Lilly and Company; GlaxoSmithKline; Novartis PharmaceuticalsCorporation; Ortho-McNeil Pharmaceuticals; Janssen Pharmaceutica and Research Foundation ;Pfizer Inc. ; Cephalon, Inc . 2, 3, 5, 34, 63

Glen O. Gabbard, M.D . Merck & Co ., Inc. 33,56

Joseph Gal, Ph .D . Forest Laboratories, Inc. 2David R. Gastfriend, M.D. Dupont Pharma; Purdue Pharma ; Bristol-Myers Squibb ; CSAT; State of Oklahoma; Earley

Corporation 33

Alan J . Gelenberg, M.D . Cyberonics; Bristol-Myers Squibb; Pfizer Inc. ; Lilly Research Laboratories,a division of Eli Lilly and Company; Wyeth Pharmaceuticals ; Hoechst Marion Roussel ; VelaPharmaceuticals ; Best Practice; Novartis Pharmaceuticals Corporation ; AstraZenecaPharmaceuticals ; G1axoSmithKlne 60,81

Mark S. George, M.D. Cyberonics ; MagStim; Netonics ; Dontec; Medtronic 9, 15, 81

S . Nassir Ghaemi, M.D . Janssen Pharmaceutica and Research Foundation ; AstraZeneca Pharmaceuticals ; NovartisPharmaceuticals Corporation; Abbott Laboratories; GlaxoSmithKline ; Forest Laboratories, Inc . ;Eli Lilly and Company 33, 62, 65, 88

Leslie H. Gise, M.D . Merck Medco Managed Care 23,70

Michael J . Gitlin, M .D . Wyeth Pharmaceuticals; Lilly Research Laboratories, a division of Eli Lilly and Company ;Pfizer Inc . ; Forest Laboratories, Inc . ; Janssen Pharmaceutica and ResearchFoundation; GlaxoSmithKline 90

Alexander H. Glassman, M.D . Pfizer Inc . ; GlaxoSmithKline; Lilly Research Laboratories, a division of Eli Lilly and Company ;Sanofi Pharmaceuticals, Inc . ; Organon Inc . 65,87

Donald C. Goff, M .D . Eli Lilly and Company; Pfizer Inc .; Janssen Pharmaceutica and ResearchFoundation; Cortex Pharmaceuticals; AstraZeneca Pharmaceuticals 3

R. Rao Gogineni, M.D . Devereux Foundation 31,84Joseph F . Goldberg, M.D . AstraZeneca Pharmaceuticals; Bristol-Myers Squibb ; Eli Lilly and Company ; Forest

Laboratories, Inc .; Abbott Laboratories; GlaxoSmithKline; Janssen Pharmaceutica andResearch Foundation; Novartis Pharmaceuticals Corporation ; R.W. Johnson ; Shire U.S .,Inc . ; Pharmacia Corporation 11, 33, 62, 63

Stephen M . Goldfmger, M.D . IVAX Pharmaceuticals; Janssen Pharmaceutica and Research Foundation ; Lilly ResearchLaboratories, a division of Eli Lilly and Company ; Pfizer Inc. ; Mallingkrodt ;AstraZeneca Pharmaceuticals 35, 71, 89

Karl Goodkin, M.D. Advanced Immunity, Inc. ; GlaxoSmithKline; Pharmacia Corporation ; Merck & Co ., Inc .;Cambridge University Press 29, 61, 89

Marianne Goodman, M.D . Janssen Pharmaceutica and Research Foundation 84,87Paul J. Goodnick, M.D. Lilly Research Laboratories, a division of Eli Lilly and Company; Pfizer Inc . ; AstraZeneca

Pharmaceuticals; GlaxoSmithKline 47Frederick K. Goodwin, M.D . Abbott Laboratories; G1axoSmithKline ; Solvay Pharmaceuticals, Inc . ; Pfizer Inc. ; Eli

Lilly and Company; Scios Nova Pharmaceuticals ; Janssen Pharmaceutica and ResearchFoundation; AstraZeneca Pharmaceuticals 33, 62, 90

Guy M. Goodwin, M.D . AstraZeneca Pharmaceuticals 8,11

Page 6: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

Presenter

Jack M. Gorman, M .D.

Elizabeth Gould, Ph.D .Tana A. Grady-Weliky, M .D.Kevin F . Gray, M.D .

Laurence L . Greenhill, M .D .

John H. Greist, M .D .

Nichole D. Grier, M.D .Mark S. Groves, M.D .Robert E. Hales, M.D .Ellen Haller, M .D .Mark B. Hamner, M.D .

Roger F. Haskett, M.D .

Keith A. Hawkins, Psy .D .Stephen H. Heidel, M .D .Howard A . Heit, M .D.David J. Hellerstein, M .D .

David C. Henderson, M .D .

John P. Hendrick, M.D .

Scott W. Henggeler, Ph.D .Charles H. Hennekens, M.D .Paula L. Hensley, M.D .

Jerrold W. Hill, Ph .D .Robert M.A. Hirschfeld, M .D .

Max Hirshkowitz, Ph .D .

Eric Hollander, M .D .Michael A . Hollifield, M .D .Rory P. Houghtalen, M .D .Robert H. Howland, M.D .Rona Hu, M.D .

James I. Hudson, M.D .

James J . Hudziak, M .D .Douglas H . Hughes, M.D .Thomas D. Hurwitz, M .D .Mustafa M. Husain

Michael Y . Hwang, M.D .Steven E . Hyler, M.D .

XXII

Manufacturer(s) Program Page #

Eli Lilly and Company; National Institute of Mental Health; NARSAD; Pfizer Inc. ; Eli Lillyand Company; Bristol-Myers Squibb ; Wyeth Pharmaceuticals; GlaxoSmithKline ; AstraZenecaPharmaceuticals ; Janssen Pharmaceutica and Research Foundation; Organon Inc. ; ForestLaboratories, Inc . ; Lundbeck ; Solvay Pharmaceuticals, Inc . ; Merck & Co., Inc . ; SanofiPharmaceuticals, Inc . ; UCB Pharma ; Purdue; Aventis ; Xenova

3,63GlaxoSmithKline

63Pfizer Inc . ; Eli Lilly and Company; GlaxoSmithKline

65Novartis Pharmaceuticals Corporation ; Lilly Research Laboratories, a division of Eli Lilly andCompany; Pfizer Inc. ; Janssen Pharmaceutica and Research Foundation

5Alza Pharmaceuticals ; Johnson and Johnson ; Celltech; Noven Pharmaceuticals; NovartisPharmaceuticals Corporation; Shire U.S., Inc. ; Somerset Pharmaceuticals, Inc .

83,98Abbott Laboratories ; GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation ; LillyResearch Laboratories, a division of Eli Lilly and Company; Organon Inc. ; Pfizer Inc . ; SanofiPharmaceuticals, Inc . ; Solvay Pharmaceuticals, Inc . ; Pharmacia Corporation; WyethPharmaceuticals ; Bristol-Myers Squibb; Forest Laboratories, Inc . ; Hoffman-LaRoche; NovartisPharmaceuticals Corporation

64Bristol-Myers Squibb

70GlaxoSmithKline

22Bristol-Myers Squibb ; Forest Laboratories, Inc .; GlaxoSmithKline

13,37Pfizer Inc . ; Bristol-Myers Squibb

52,76AstraZeneca Pharmaceuticals; Lilly Research Laboratories, a division of Eli Lilly and Company ;Janssen Pharmaceutica and Research Foundation ; Bristol-Myers Squibb

55Eli Lilly and Company; GlaxoSmithKline ; Forest Laboratories, Inc . ; Pfizer Inc . ; WyethPharmaceuticals

23Eli Lilly and Company

95Integrated Insights (employer)

7Purdue Pharma; McNeil Pharmaceutical; Abbott Laboratories

62Pfizer Inc. ; Eli Lilly and Company; GlaxoSmithKline; Bristol-Myers Squibb; Forest Laboratories,Inc. ; Dista Products; Wyeth Pharmaceuticals; Merck & Co., Inc . ; National Institute of MentalHealth; National Institute on Drug Abuse

92Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation ; Pfizer Inc.;AstraZeneca Pharmaceuticals

37,64AstraZeneca Pharmaceuticals; Forest Laboratories, Inc . ; GlaxoSmithKline; Lilly ResearchLaboratories, a division of Eli Lilly and Company ; Pfizer Inc .; Organon Inc. ; Wyeth Pharmaceuticals

48MST Services, Inc .

95Pfizer Inc.

64Janssen Pharmaceutica and Research Foundation ; Pfizer Inc . ; Eli Lilly and Company; ForestLaboratories, Inc . ; Wyeth Pharmaceuticals ; Abbott Laboratories ; NovartisPharmaceuticals Corporation; Parke-Davis, Division of Warner-Lambert Company

77Pfizer Inc.

92Abbott Laboratories ; Bristol-Myers Squibb; GlaxoSmithKline ; Organon Inc.; WyethPharmaceuticals ; Forest Laboratories, Inc .; Eli Lilly and Company; Pfizer Inc. ;Pharmacia Corporation; Janssen Pharmaceutica and Research Foundation ; Sepracor, Inc .;Novartis Pharmaceuticals Corporation

3,11Wyeth Pharmaceuticals ; Searle ; Lorex Bertek; Pharmacia Corporation ; Cephalon, Inc .;Merck & Co ., Inc. ; Lilly Research Laboratories, a division of Eli Lilly and Company; Sepracor,Inc. ; Takeda Pharmaceuticals

78Solvay Pharmaceuticals, Inc .; Abbott Laboratories; Wyeth Pharmaceuticals

34, 64, 84, 87Eli Lilly and Company

77Wyeth Pharmaceuticals

89Cyberonics, Inc .

52Janssen Pharmaceutica and Research Foundation ; Pfizer Inc . ; AstraZenecaPharmaceuticals ; Lilly Research Laboratories, a division of Eli Lilly and Company ;Bristol-Myers Squibb

13Eli Lilly and Company; Pfizer Inc . ; Ortho-McNeil Pharmaceuticals; Elan Pharmaceuticals ; Merck& Co., Inc .; Knoll

86Pfizer Inc. ; GlaxoSmithKline; Eli Lilly and Company

64Janssen Pharmaceutica and Research Foundation

63Searle; Wyeth Pharmaceuticals

27,78National Institute of Mental Health; Eli Lilly and Company; Bristol-Myers Squibb; NovartisPharmaceuticals Corporation; Janssen Pharmaceutica and Research Foundation ; GlaxoSmithKline;Pfizer Inc .

52,64Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation

19,30Janssen Pharmaceutica and Research Foundation ; Eli Lilly and Company

14,56

Page 7: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

Presenter

Naveed Iqbal, M .D.

Richard S . Jackson, M .D .

Richard L . Jaffe, M .D .Philip G. Janicak, M .D .

Kathleen Jarboe, R.N.Robin B. Jarrett, Ph.D .Dilip V. Jeste, M .D .

Michael D . Jibson, M .D .

David C . Jimerson, M.D .David E . Joranson, M.S.W.Ned H. Kalin, M.D.

John M. Kane, M.D .

Shitij Kapur, M .D .

David J . Katzelnick, M .D.

Paul E . Keck, Jr., M .D.

Samuel J . Keith, M.D .

Martin B. Keller, M.D .

Charles H. Kellner, M .D .Justine M. Kent, M.D .Ronald C . Kessler, Ph.D .Terence A . Ketter, M .D .

Paul A . Kettl, M .D.

Clinton D . Kilts, Ph .D .

Steven A . King, M.D .Ellen Kingsley, M.A.

Herbert D . Kleber, M.D .Mitchel A . Kling, M.D .Harold W. Koenigsberg, M.D .Anthony L. Komaroff, M.D .

Manufacturer(s) Program Page #

Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation ; GlaxoSmithKline ;Pfizer Inc . ; AstraZeneca Pharmaceuticals; Novartis Pharmaceuticals Corporation ; Bristol-MyersSquibb

19Abbott Laboratories; AstraZeneca Pharmaceuticals ; Lilly Research Laboratories, a division ofEli Lilly and Company ; Forest Laboratories, Inc . ; Pfizer Inc. ; Bristol-Myers Squibb; JanssenPharmaceutica and Research Foundation

7Pfizer Inc .

38Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb ; Genentech; NationalInstitutes of Health; Pfizer Inc . ; Novartis Pharmaceuticals Corporation ; GlaxoSmithKline;Sepracor, Inc .; Abbott Laboratories ; Lilly Research Laboratories, a division of Eli Lilly andCompany

24,38Janssen Pharmaceutica and Research Foundation; Pfizer Inc. ; Eli Lilly and Company

9Cyberonics, Inc .

9AstraZeneca Pharmaceuticals ; Bristol-Myers Squibb; Eli Lilly and Company; JanssenPharmaceutica and Research Foundation; Pfizer Inc .

37AstraZeneca Pharmaceuticals ; Janssen Pharmaceutica and Research Foundation ; Lilly ResearchLaboratories, a division of Eli Lilly and Company ; Pfizer Inc.

85Abbott Laboratories

7Ortho-McNeil Products; Janssen Pharmaceutica and Research Foundation ; Purdue Pharma

62GlaxoSmithKline; Wyeth Pharmaceuticals ; Janssen Pharmaceutica and Research Foundation ;Forest Laboratories, Inc . ; Neurocrine

11Pfizer Inc. ; Janssen Pharmaceutica and Research Foundation ; NovartisPharmaceuticals Corporation; Abbott Laboratories ; Bristol-Myers Squibb; Lundbeck; LillyResearch Laboratories, a division of Eli Lilly and Company ; AstraZeneca Pharmaceuticals

9,13Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation ; Neuromolecular,Inc. ; Pfizer Inc. ; Wyeth Pharmaceuticals; AstraZeneca Pharmaceuticals ; Bristol-MyersSquibb; GlaxoSmithKline; Solvay Pharmaceuticals, Inc .

82,96Abbott Laboratories ; AstraZeneca Pharmaceuticals; GlaxoSmithKline ; Merck & Co ., Inc .;Novartis Pharmaceuticals Corporation; Pfizer Inc . ; Solvay Pharmaceuticals, Inc . ; Mar-ArthurFoundation; Organon Inc. ; Robert Wood Johnson Foundation; Wyeth Pharmaceuticals ;Forest Laboratories, Inc .; Lilly Research Laboratories, a division of Eli Lilly andCompany; Pharmacia Corporation ; Johnson and Johnson ; Healthcare Technology Systems, Inc.

60Abbott Laboratories; AstraZeneca Pharmaceuticals; Bristol-Myers Squibb, GlaxoSmithKline;Lilly Research Laboratories, a division of Eli Lilly and Company ; Janssen Pharmaceutica andResearch Foundation; Pfizer Inc. ; Wyeth Pharmaceuticals ; Merck & Co ., Inc .

11, 81, 93Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb ; Pfizer/Inc . ; NovardsPharmaceuticals Corporation

9Pfizer Inc .; Bristol-Myers Squibb ; Forest Laboratories, Inc .; Wyeth Pharmaceuticals ; Merck& Co., Inc. ; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories,a division of Eli Lilly and Company; Organon Inc . ; Pharmacia Corporation ; WyethPharmaceuticals; GlaxoSmithKline ; AstraZeneca Pharmaceuticals ; Mitsubishi Pharmaceuticals;Scirex; Vela Pharmaceuticals ; Sepracor, Inc.; Somerset Pharmaceuticals, Inc .; SanofiPharmaceuticals, Inc. ; Cypress Bioscience

11,60Somatics, Inc.

1,38Solvay Pharmaceuticals, Inc.

63Pfizer Inc .

10Abbott Laboratories ; Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company;Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Bristol-Myers Squibb ; Elan Pharmaceuticals ;AstraZeneca Pharmaceuticals; Shire U.S., Inc. ; Cephalon, Inc .

5,63Pfizer Inc . ; Organon Inc .; Novartis Pharmaceuticals Corporation ; Lilly Research Laboratories, adivision of Eli Lilly and Company ; AstraZeneca Pharmaceuticals ; Janssen Pharmaceutica andResearch Foundation; Wyeth Pharmaceuticals ; Manor HealthCare; Abbott Laboratories; Bristol-Myers Squibb

42,80Bristol-Myers Squibb ; Janssen Pharmaceutica and Research Foundation; Forest Laboratories, Inc . ;AstraZeneca Pharmaceuticals; GlaxoSmithKline

63Wyeth Pharmaceuticals; Janssen Pharmaceutica and Research Foundation ; Purdue; Endo

2Additude Magazine; Alza Pharmaceuticals; Shire U .S., Inc. ; Abbott Laboratories ; Bristol-MyersSquibb; GlaxoSmithKline; Organon Inc. ; Wyeth Pharmaceuticals ; Forest Laboratories, Inc . ;Eli Lilly and Company; Pharmacia Corporation ; Janssen Pharmaceutica and Research Foundation;Novartis Pharmaceuticals Corporation

38Schering Plough

34, 43, 66Cyberonics, Inc .

52Janssen Pharmaceutica and Research Foundation

74,84Cephalon, Inc.

86

XXIII

Page 8: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

Presenter

T.illi Kopala, M.D .

Susan G. Kornstein, M.D .

Thomas R. Kosten, M.D .Robert A. Kowatch, M.D .Diana M. Koziupa, M .D .Lois Krahn, M.D .Henry R. Kranzler, M .D .Christopher J . Kratochvil, M .D .Ranga K. Krishnan, M.D .

Elisabeth J.S . Kunkel, M.D .

David J . Kupfer, M .D .Raymond W. Lam, M.D .

William B. Lawson, M.D.

Arthur L. Lazarus, M .D .Ellen Leibenluft, M .D .

Alan I. Levenson, M.D.Frances R. Levin, M .D .Saul M. Levin, M.D .Jeffrey M. Levine, M.D .David A. Lewis, M .D .Jeffrey A . Lieberman, M .D .

Barry D. Liebowitz, Ph .D .Walter Ling, M .D .Paul S . Links, M.D .Sarah H. Lisanby, M.D.Maria D. Llorente, M .D .Miklos F. Losonczy, M.D.

Joe Lovelace, J .D .R. Bruce Lydiard, M .D .

Constanine G. Lyketsos, M.D .

Gerald A. Maguire, M.D .Husseini K. Manji, M.D .

Lauren B. Marangell, M .D .

John S. March, M.D .

Stephen R. Marder, M.D .

Manufacturer(s)

Program Page #

AstraZeneca Pharmaceuticals; Abbott Laboratories ; Janssen Pharmaceutica and ResearchFoundation; Bristol-Myers Squibb; Eli Lilly and Company; Lundbeck; Novartis PharmaceuticalsCorporation; Pfizer Inc.

13Pfizer Inc . ; Bristol-Myers Squibb ; Lilly Research Laboratories, a division of Eli Lilly and Company ;GlaxoSmithKline ; Forest Laboratories, Inc . ; Wyeth Pharmaceuticals ; Pharmacia Corporation ;Mitsubishi; Biovail; Berlex Laboratories; Novartis Pharmaceuticals Corporation ; Merck & Co ., Inc .Cyberonics, Inc.

6,9Abbott Laboratories ; Schering Pharmaceuticals

66,95Abbott Laboratories ; Solvay Pharmaceuticals, Inc .

5GlaxoSmithKlne; Organon Inc. ; Wyeth Pharmaceuticals ; Eli Lilly and Company

97Wyeth Pharmaceuticals

8, 13, 78Best Practice/Drug Abuse Sciences ; Contral Pharma

55Eli T .illy and Company; Alza Pharmaceuticals ; Novartis Pharmaceuticals Corporation

3,83Eisai Inc. ; Novartis Pharmaceuticals Corporation ; Pfizer Inc . ; Forest Laboratories, Inc . ; AbbottLaboratories ; Bristol-Myers Squibb ; Dupont Pharma; GlaxoSmithKline ; Janssen PharmaceuticaAnd Research Foundation; Merck & Co., Inc. ; Organon Inc . ; Pharmacia Corporation ; SomersetPharmaceuticals, Inc .

6,11Forest Laboratories, Inc. ; Parke-Davis, Division of Warner-Lambert Company ; WyethPharmaceuticals ; Pfizer Inc .Pfizer Inc. ; Eli Lilly and Company; Forest Laboratories, Inc .

3, 34, 63Pfizer Inc. ; Eli Lilly and Company; Pharmacia Corporation ; Lundbeck; Servier ; Litebook;Organon Inc. ; Wyeth Pharmaceuticals

2AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation ; Lilly ResearchLaboratories, a division of Eli Lilly and Company

17, 58, 70, 94Pfizer Inc.

25,93Pfizer Inc . ; Wyeth Pharmaceuticals ; Lilly Research Laboratories, a division of Eli Lilly andCompany; Abbott Laboratories; Johnson and Johnson

3Psychiatrists' Purchasing Group, Inc .

18Eli Lilly and Company; GlaxoSmithKlne

34, 44, 55SAMHSA/CSAT

90,93Wyeth Pharmaceuticals; GlaxoSmithKline ; Pfizer Inc.

44AstraZeneca Pharmaceuticals

12Bristol-Myers Squibb ; Novartis Pharmaceuticals Corporation; Lilly Research Laboratories, adivision of Eli Lilly and Company ; Janssen Pharmaceutica and Research Foundation; PfizerInc .; AstraZeneca Pharmaceuticals; Hoechst Marion Roussel; Pharmacia Corporation

9, 10, 12Forest Laboratories, Inc .

85Roxane Laboratories; Schering Plough

50Eli Lilly and Company, Canada, Inc .

81MagStim Company

14Abbott Laboratories

32Eli Lilly and Company ; Janssen Pharmaceutica and Research Foundation; AstraZenecaPharmaceuticals

19Janssen Pharmaceutica and Research Foundation

9Bristol-Myers Squibb; GlaxoSmithKline; Parke-Davis, Division of Warner-Lambert Company ;Pfizer Inc . ; Eli Lilly and Company; Pharmacia Corporation ; Forest Laboratories, Inc . ; RocheLaboratories, a member of the Roche Group ; AstraZeneca Pharmaceuticals

10, 61, 87Pfizer Inc . ; Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, aDivision of Eli T .illy and Company ; Dupont Pharma; Abbott Laboratories ; Eisai Inc . ;Bristol-Myers Squibb

7Eli Lilly and Company;Janssen Pharmaceutica and Research Foundation ; Pfizer Inc.

6Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica andResearch Foundation ; Oxford Glycosciences ; Chiron ; AstraZeneca Pharmaceuticals ; AbbottLaboratories;'Pharmacia Corporation

12National Institutes of Health ; Stanley Foundation ; Eli Lilly and Company ; Martek Biosciences;Cyberonics; Abbott Laboratories; Pfizer Inc . ; Parke-Davis, Division of Warner-LambertCompany; Forest Laboratories, Inc . ; Bristol-Myers Squibb; GlaxoSmithKlne; JanssenPharmaceutica and Research Foundation; Wyeth Pharmaceuticals ; Novartis PharmaceuticalsCorporation

9, 11, 81Solvay Pharmaceuticals, Inc. ; Pfizer Inc . ; GlaxoSmithKline ; Wyeth Pharmaceuticals ; ShireU.S ., Inc . ; Lilly Research Laboratories, a division of Eli Lilly and Company ; AlzaPharmaceuticals ; Somerset Pharmaceuticals, Inc . ; Medeva; Celgene; Bristol-Myers Squibb 87Janssen Pharmaceutica and Research Foundation ; Eli Lilly and Company ; Pfizer Inc. ;AstraZeneca Pharmaceuticals; Bristol-Myers Squibb

75

9,38

Page 9: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

XXV

Presenter Manufacturer(s) Program Page #

John C. Markowitz, M .D . National Institute of Mental Health; Pfizer Inc . ; Lilly Research Laboratories, a division ofEli Lilly and Company; Bristol-Myers Squibb ; Forest Laboratories, Inc . ; Organon Inc. ; AmericanPsychiatric Press Inc . ; Basic Books; Wyeth Pharmaceuticals 6, 48, 66, 96

Robert C. Marks, M .D . Pfizer Inc . ; Janssen Pharmaceutica and Research Foundation 24Prakash S. Masand, M.D . AstraZeneca Pharmaceuticals ; Janssen Pharmaceutica and Research Foundation ; GlaxoSmithKline;

Forest Laboratories, Inc . ; Wyeth Pharmaceuticals ; Health Care Technology; Pfizer Inc . ; AbbottLaboratories; Bristol-Myers Squibb; Novartis Pharmaceuticals Corporation ; Pfizer Inc. ; Searle;Solvay Pharmaceuticals, Inc. 3, 37, 63, 96

Donna Masterman, M .D . Pfizer Inc . ; Eisai Inc . ; Novartis Pharmaceuticals Corporation ; Janssen Pharmaceutica andResearch Foundation; Bayer Corporation, Pharmaceutical Division ; Eli Lilly and Company;Fugisawa; Neotherapeutica ; Sanofi Pharmaceuticals, Inc . ; Pharmacia Corporation 86

Matig R. Mavissakalian, M.D . Pfizer Inc. ; Forest Laboratories, Inc . 22Una D. McCann, M.D . Pfizer Inc. ; Bristol-Myers Squibb 81

Richard H. McCarthy, M .D . Lilly Research Laboratories, a division of Eli Lilly and Company ; AstraZeneca Pharmaceuticals ;Janssen Pharmaceutica and Research Foundation; Novartis Pharmaceuticals Corporation ;Parke-Davis, Division of Warner-Lambert Company 71

Christopher J . McDougle, M.D . Janssen Pharmaceutica and Research Foundation; Pfizer Inc. ; Eli Lilly and Company 14

Susan L. McElroy, M.D . Abbott Laboratories ; Eli Lilly and Company; Forest Laboratories, Inc . ; Elan Pharmaceuticals ;GlaxoSmithKline ; Bristol-Myers Squibb ; Janssen Pharmaceutica and Research Foundation;Ortho-McNeil Pharmaceuticals 86

Joseph P . McEvoy, M.D. Bristol-Myers Squibb 9,10

Patrick D. McGorry, Ph .D . Janssen Pharmaceutica and Research Foundation ; Eli Lilly and Company ; Pfizer Inc . ; NovartisPharmaceuticals Corporation; Bristol-Myers Squibb 9

Alan J. Mendelowitz, M .D . Pfizer Inc. ; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation ;Lilly Research Laboratories, a division of Eli Lilly and Company 64,85

Ricardo P . Mendoza, M.D . Pfizer Inc . ; Forest Laboratories, Inc . ; Janssen Pharmaceutica and Research Foundation 70

Matthew A. Menza, M .D . Cephalon, Inc. 92David Michelson, M .D . Eli Lilly and Company (employer) 47

Frederick E . Miller, M .D . Pfizer Inc . 74

Matthew S . Miller, Ph.D . Cephalon, Inc. (employer) 49Jacobo E. Mintzer, M.D . Abbott Laboratories ; Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc . ;

Jansseo Pharmaceutica and Research Foundation ; Pfizer Inc . 7, 25, 85

Shaila Misri, M.D . GlaxoSmithKline; Wyeth Pharmaceuticals 8James E. Mitchell, M.D . Lilly Research Laboratories, a division of Eli Lilly and Company ; Abbott Laboratories 7,30

Gary S. Moak, M.D. Eisai Inc . ; Pfizer Inc. ; Janssen Pharmaceutica and Research Foundation ; Eli Lilly and Company 2

Francisco A. Moreno, M.D . Solvay Pharmaceuticals, Inc . 18,64

Philip Morris, Ph.D . Dupont Pharma 83

Greer M . Murphy, M.D . Organon Inc . 9Dominique L. Musselman, M .D . DANA Foundation; GlaxoSmithKline; National Institutes of Health ; Schering Plough; Forest

Laboratories, Inc . ; Parke-Davis, Division of Warner-Lambert Company ; Pfizer Inc . ; WyethPharmaceuticals 13

Ziad H . Nahas, M .D . Cyberonics, Inc. ; Neotonus, Inc. 14,52

Henry A. Nasrallah, M .D . AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and Research Foundation : Pfizer Inc . ;Wyeth Pharmaceuticals ; Forest Laboratories, Inc . ; National Institutes of Health ; Bristol-Myers

Squibb 13,37

Rebecca R. Neal, M.D . Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica andResearch Foundation 19

J. Craig Nelson, M .D . Abbott Laboratories; Bristol-Myers Squibb ; Eli Lilly and Company ; Forest Laboratories, Inc .;GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation ; Organon Inc . ; Pfizer Inc.;Pharmacia Corporation; Wyeth Pharmaceuticals 6,64

Charles B. Nemeroff, M.D . Abbott Laboratories ; AstraZeneca Pharmaceuticals ; Bristol-Myers Squibb; Forest Laboratories,

Inc . ; Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company ; Organon Inc. ;Pfizer Inc. ; Pharmacia Corporation; GlaxoSmithKline; Solvay Pharmaceuticals, Inc . ; WyethPharmaceuticals ; Acadia Pharmaceuticals; Cypress Biosciences; Otsuka Pharmaceuticals ;Merck & Co ., Inc. ; Neurocrine Biosciences ; Sanofi Pharmaceuticals, Inc . ; Vela 11,63

John W. Newcomer, M .D . Janssen Pharmaceutica and Research Foundation; Eli Lilly and Company; Pfizer Inc . ;AstraZeneca Pharmaceuticals 3

Thomas Newton, M.D . Cypress Bioscience 52

Andrew A. Nierenberg, M .D . Lilly Research Laboratories, a division of Eli Lilly and Company ; Wyeth Pharmaceuticals;

GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation ; Innapharma; Bristol-MyersSquibb; Cyberonics; Lichtner; Pfizer Inc . ; Forest Laboratories, Inc . 2,6

Carol S. North, M.D . GlaxoSmithKline ; Bristol-Myers Squibb 8,97

Andrei Novae, M.D . Pfizer Inc . ; G1axoSmithKline; Forest Laboratories, Inc . 71H. George Nurnberg, M.D . Pfizer Inc. ; Eli Lilly and Company; GlaxoSmithKline 75Charles P . O'Brien, M .D . Dupont Pharma 18, 83, 94

Page 10: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

Presenter

Mary B . O'Malley, M.D .N. Kalaya Okereke, M.D .Lewis A. Opler, M .D .Michael W. Otto, Ph.D.

Michael J . Owens, Ph.D.Michelle T. Pato, M.D .

Diana O. Perkins, M.D .

Frederick Petty, M .D .

Edmond H.T. Pi, M .D .Debra A. Pinals, M.D .Daniel Pine, M .D .Mark H . Pollack, M.D .

Robert M. Post, M.D .

Marc N. Potenza, M.D .Steven G. Potkin, M.D .David W. Preven, M.D.Annelle B. Primm, M.D .Jefferson B. Prince, M.D.

Andres J . Pumariega, M .D .Arturo G. Quiason, M.D .

Ljiljana Radulovic, M.D .Paul M. Ramirez, Ph.D .Mark H . Rapaport, M .D .

Natalie L. Rasgon, M.D .Scott L . Rauch, M.D .

William T. Regenold, M .D .

William E. Reichman, M.D .

Roy O. Resnikoff, M .D.

Kerry J . Ressler, M .D .Charles F . Reynolds III, M .D .Mary Ann Richardson, Ph.D .Mark A. Riddle, M .D .

Gustavo C. Roman, M.D .Steven P . Roose, M .D .

Mark R . Rosekind, Ph.D.Jerrold F. Rosenbaum, M.D .

Thomas Roth, Ph.D .

Barbara O . Rothbaum, Ph.D .

XXVI

Manufacturer(s)

Program Page #

Cephalon, Inc .

49,86AstraZeneca Pharmaceuticals

47Multi-Health Systems

5, 19, 25, 30Pharmacia Corporation ; Janssen Pharmaceutica and Research Foundation; Pfizer Inc. ;Anciie Pharma; GlaxoSmithKline; Eli Lilly and Company; Psychological Corporation; AbbottLaboratories

11,57Forest Laboratories, Inc . ; GlaxoSmithKline; Abbott Laboratories ; Eli Lilly and Company

2, 63, 65Solvay Pharmaceuticals, Inc. ; Lilly Research Laboratories, a division of Eli Lilly and Company ;Forest Laboratories, Inc . ; Pfizer Inc.

38Lilly Research Laboratories, a division of Eli Lilly and Company ; Pfizer Inc. ; AstraZenecaPharmaceuticals ; Janssen Pharmaceutica and Research Foundation; Bristol-Myers Squibb

9, 13, 95Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of EliLilly and Company ; Pfizer Inc.

87Eli Lilly and Company

70Janssen Pharmaceutica and Research Foundation

90Solvay Pharmaceuticals, Inc .; Bristol-Myers Squibb ; Wyeth Pharmaceuticals

35,63Bristol-Myers Squibb; Forest Laboratories, Inc.; Lilly Research Laboratories, a division of EliLilly and Company; Parke-Davis, Division of Warner-Lambert Company ; Pfizer Inc .;GlaxoSmithKline; Solvay Pharmaceuticals, Inc . ; Wyeth Pharmaceuticals

10Abbott .Laboratories ; Bristol-Myers Squibb; GlaxoSmithKline ; Janssen Pharmaceutica andResearch Foundation; Novartis Pharmaceuticals Corporation ; Lilly Research Laboratories, adivision of Eli Lilly and Company ; Parke-Davis, Division of Warner-Lambert Company ;Pfizer Inc. ; Pharmacia Corporation; UCB Pharma

62,63GlaxoSmithKline; Forest Laboratories, Inc .

83Novartis Pharmaceuticals Corporation

64Forest Laboratories, Inc. ; Pfizer Inc.

26Pfizer Inc.

43GlaxoSmithKline; Forest Laboratories, Inc . ; Lilly Research Laboratories, a division of Eli Lillyand Company; Alza Pharmaceuticals

1,78Center for Mental Health Services

90Wyeth Pharmaceuticals; Novartis Pharmaceuticals Corporation ; Janssen Pharmaceutica andResearch Foundation; Pfizer Inc.

25Abbott Laboratories

92Multi-Health Systems

5Abbott Laboratories ; Forest Laboratories, Inc . ; GlaxoSmithKline; Pfizer Inc. ; JanssenPharmaceutica and Research Foundation ; Lilly Research Laboratories, a division of Eli Lillyand Company; Sanofi Pharmaceuticals, Inc . ; Pharmacia Corporation ; Robert Wood Johnson ;UBC Pharma; Wyeth Pharmaceuticals

33Forest Laboratories, Inc .

2,34GlaxoSmithKline; Janssen Pharmaceutica and Research Foundation ; Lilly Research Laboratories,a division of Eli Lilly and Company; Pfizer Inc. ; Solvay Pharmaceuticals, Inc .

8Pfizer Inc . ; Lilly Research Laboratories, a division of Eli Lilly and Company ; AstraZenecaPharmaceuticals ; Novartis Pharmaceuticals Corporation

43Eisai Inc. ; Pfizer Inc. ; Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation;Bristol-Myers Squibb; Organon Inc. ; Forest Laboratories, Inc .

2,7Pfizer Inc . ; Bristol-Myers Squibb; Forest Laboratories, Inc . ; AstraZeneca Pharmaceuticals ; LillyResearch Laboratories, a division of Eli Lilly and Company

66,93Pfizer Inc . ; GlaxoSmithKline

63GlaxoSmithKline ; Forest Laboratories, Inc .; Organon Inc .

5,9Scientific Hospital Supplies, Ltd .

75Best Practice ; Excerpta Medical; Janssen Pharmaceutica and Research Foundation; Bristol-MyersSquibb ; Shire U.S ., Inc . ; Solvay Pharmaceuticals, Inc . ; National Institute of Mental Health

98Eisai Inc .

86Forest Laboratories, Inc. ; GlaxoSmithKline; Wyeth Pharmaceuticals ; Bristol-Myers Squibb; Eli Lillyand Company ; Organon Inc. ; Pharmacia Corporation

5,9Wyeth Pharmaceuticals

13Cyberonics ; Eli Lilly and Company ; Forest Laboratories, Inc .; Lichtwer Pharma; Organon Inc .;Wyeth PharmaceuticalsWyeth Pharmaceuticals; Sanofi Pharmaceuticals, Inc . ; Aventis ; Sepracor, Inc . ; Neurocrine ;Merck & Co., Inc. ; Proctor and Gamble; Takeda Pharmaceuticals ; Novartis PharmaceuticalsCorporation; Lilly Research Laboratories, a division of Eli Lilly and Company ; Bristol-MyersSquibb; Forest Laboratories, Inc .Pfizer Inc. ; Bristol-Myers Squibb ; Wyeth Pharmaceuticals; Virtually Better; SomersetPharmaceuticals, Inc .

8,11

2

37,85

Page 11: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

XXVII

Presenter Manufacturer(s) Program Page #

A. John Rush, M .D . Cyberonics; Robert Wood Johnson Foundation; National Institute of Mental Health ; StanleyFoundation; Wyeth Pharmaceuticals; Abbott Laboratories; Bristol-Myers Squibb ; Eli Lillyand Company; Forest Laboratories, Inc . ; GlaxoSmithKline; Janssen Pharmaceutica andResearch Foundation ; Merck & Co ., Inc . ; Pfizer Inc. ; Pharmacia Corporation 9,60

Donna H. Ryan, M.D . Wyeth Pharmaceuticals ; Abbott Laboratories ; Boots Pharmaceuticals; Roche Laboratories, amember of the Roche Group ; Amgen; Bristol-Myers Squibb ; Ergo; G1axoSmithKline; Parke-Davis, Division of Warner-Lambert Company; Warner Lambert; Regeneron Pharmaceuticals ;Schering Plough ; Proctor and Gamble ; TAP Pharmaceuticals; Wyeth Pharmaceuticals 65

J. Michael Ryan, M .D . Eisai Inc .; Pfizer Inc. ; AstraZeneca Pharmaceuticals; Janssen Pharmaceutica and ResearchFoundation; Novartis Pharmaceuticals Corporation ; Eli Lilly and Company; Abbott Laboratories 2,86

Neal D . Ryan, M .D . Pfizer Inc. ; Abbott Laboratories ; Hoffman-LaRoche ; AstraZeneca Pharmaceuticals ;GlaxoSmithKline; Wyeth Pharmaceuticals 13

Gary S. Sachs, M.D. Abbott Laboratories ; GlaxoSmithKline ; Janssen Pharmaceutica and Research Foundation ; Eli Lillyand Company; Bristol-Myers Squibb; Novartis Pharmaceuticals Corporation ; Elan ; SanofiPharmaceuticals, Inc.; Scios Nova Pharmaceuticals ; Solvay Pharmaceuticals, Inc . ; AstraZenecaPharmaceuticals 8, 11, 92

Harold A . Sackeim, Ph.D . Pfizer Inc . ; Forest Laboratories, Inc .; Cyberonics 5, 9, 81

Mary Sano, Ph.D . Novartis Pharmaceuticals Corporation; Janssen Pharmaceutica and Research Foundation ;Forest Laboratories, Inc. ; Merck & Co ., Inc . ; Fujisawa; Pfizer Inc . 85

Norman Sartorius, M.D . Bristol-Myers Squibb 6,60

Seddon R. Savage, M.D. Muro Asta Medica; Ortho-McNeil Pharmaceuticals; Janssen Pharmaceutica and ResearchFoundation; Purdue Pharma 62

Franklin R. Schneier, M .D . Forest Laboratories, Inc . ; Solvay Pharmaceuticals, Inc . ; Somerset Pharmaceuticals, Inc . ;GlaxoSmithKline 61

Nina R. Schooler, Ph .D . Janssen Pharmaceutica and Research Foundation; Pfizer Inc. ; Novartis PharmaceuticalsCorporation 30,64

S. Charles Schulz, M .D . Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division ofEli Lilly and Company; AstraZeneca Pharmaceuticals ; Pfizer Inc . 13,87

Dean Schuyler, M .D . Wyeth Pharmaceuticals ; Pfizer Inc . 27

Marcia Scott, M .D . Prudential 7

Yvette Sealy, Ph.D . Bedford Community Health Center 44

Larry J. Seidman, Ph.D . Forest Laboratories, Inc. ; GlaxoSmithKline; Shire U.S ., Inc. 86

Stuart N. Seidman, M.D. Forest Laboratories, Inc. ; GlaxoSmithKlne 2, 34, 47

Shawn C. Shea, M.D . GlaxoSmithKline 15

M. Katherine Shear, M .D . Wyeth Pharmaceuticals 11

David V. Sheehan, M .D . Abbott Laboratories ; Alza Pharmaceuticals; Forest Laboratories, Inc . ; GlaxoSmithKline; LaytonBioscience; Lilly Research Laboratories, a division of Eli Lilly and Company; Lundbeck ; OrganonInc . ; Pharmacia Corporation ; Pfizer Inc. ; Pierre Fabre ; Wyeth Pharmaceuticals ; American MedicalAssociation ; Anclote Foundation ; Bristol-Myers Squibb ; Eisai Inc. ; International Clinical Research ;Janssen Pharmaceutica and Research Foundation ; Kali Duphar Laboratories; Mead JohnsonLaboratories; Merck & Co., Inc. ; Novartis Pharmaceuticals Corporation ; Parke-Davis, Division ofWarner-Lambert Company; Quintiles; Sandoz Pharmaceuticals Corporation; Synth2labo; TampaGeneral Hospital-University Psychiatry Center ; TAP Pharmaceuticals; Warner ChilcottPharmaceutical Company; Worldwide Clinical Trials ; AstraZeneca Pharmaceuticals ; BoehringerIngelheim; Boots Pharmaceuticals; Charter Hospitals ; Ciba Geigy Corporation, PharmaceuticalDivision ; Dista Products; Excerpta Medica Asia; Humana; ICI ; Marion Merrill Dow; McNeilPharmaceuticals; Organon Inc. ; Novo Nordisk Pharmaceuticals Inc ., Rhone-Poulenc RorerPharmaceuticals ; Roerig; Schering Plough; Corporation ; Solvay Pharmaceuticals, Inc . ; LaytonBioscience; Medical Outcome Systems 8,13

Richard C . Shelton, M .D . Eli Lilly and Company; GlaxoSmithKlne; Janssen Pharmaceutica and Research Foundation ;Pfizer Inc. ; Rhone-Poulenc Rorer Pharmaceuticals ; Sanofi Pharmaceuticals, Inc . ; WyethPharmaceuticals ; AstraZeneca Pharmaceuticals ; Abbott Laboratories ; Bristol-Myers Squibb;Solvay Pharmaceuticals, Inc . 65, 87, 96

Larry J . Siever, M .D . Janssen Pharmaceutica and Research Foundation 65, 84, 87

Linmarie Sikich, M .D . Janssen Pharmaceutica and Research Foundation; Lilly Research Laboratories, a division of EliLilly and Company 48

Deborah R. Simkin, M.D . Pfizer Inc. ; Alza Pharmaceuticals ; GlaxoSmithKline 83,84

Gregory E. Simon, M .D . Group Health Cooperative; Eli Lilly and Company 59

Naomi M. Simon, M .D . Bristol-Myers Squibb; Forest Laboratories, Inc . ; GlaxoSmithKline; Lilly ResearchLaboratories, a division of Eli Lilly and Company ; Pfizer Inc .; Wyeth Pharmaceuticals 10

Samuel G. Siris, M.D . Pfizer Inc . ; Eli Lilly and Company ; Merck & Co ., Inc . 30

Gary W. Small, M.D . Pfizer Inc . ; Janssen Pharmaceutica and Research Foundation; Abbott Laboratories; LillyResearch Laboratories, a division of Eli Lilly and Company ; Novartis PharmaceuticalsCorporation; GlaxoSmithKline; Organon Inc . ; Forest Laboratories, Inc .; Eisai Inc . 86

Page 12: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

Presenter

Michael W. Smith, M.D .

Thomas J. Spencer, M.D .

Stephen M . Stahl, M .D .

Judy L. Stange, Ph .D .Dan J. Stein, M.D .Murray B. Stein, M.D .

Hans Steiner, M .D.Jonathan W. Stewart, M .D .Nada L. Stotland, M.D .Eric C . Strain, M .D .David L. Sultzer, M.D .

Patricia Suppes, M.D .

Alan C. Swann, M .D .

Holly A. Swartz, M.D .Carol A. Tamminga, M.D.Rajiv Tandon, M.D .

Steven D. Targum, M.D .Pierre N . Tariot, M.D .

Michael E . Thase, M.D .

Diane S . Thompson, M.D .Joyce A. Tinsley, M.D .Mauricio F. Token, M .D.Martin G. Tracy, J .D .Madhukar H . Trivedi, M.D .

John W. Tsuang, M.D .

Phebe M. Tucker, M.D .Atilla Turgay, M.D.

Michael A. Van Ameringen, M .D .

Meera Vaswani, Ph .D .Sanjeev Venkataraman, M.D.Sumer Verma, M .D.

XXVIII

Manufacturer(s) Program Page #

Janssen Pharmaceutica and Research Foundation ; Lilly Research Laboratories, a division ofEli Lilly and Company; GlaxoSmithKline; AstraZeneca Pharmaceuticals; Kaiser; Bristol-Myers Squibb; Pfizer Inc. ; Upsher-Smith; National Institute of Mental Health

5Abbott Laboratories ; Alza Pharmaceuticals ; Boston Life Sciences ; Bristol-Myers Squibb; EisaiInc. ; GlaxoSmithKline; Gliatech; Lilly Research Laboratories, a division of Eli Lilly and Company ;Medeva; Novartis Pharmaceuticals Corporation ; Pfizer Inc. ; Shire U.S., Inc. ; SolvayPharmaceuticals, Inc . ; Wyeth Pharmaceuticals

3,86Bayer Corporation, Pharmaceutical Division; Boehringer-Ingelheim; Bristol-Myers Squibb;Eli Lilly and Company; Forest Laboratories, Inc . ; GlaxoSmithKline; Janssen Pharmaceuticaand Research Foundation; Lundbeck; Organon Inc. ; Parke-Davis, Division of Warner-LambertCompany; Pfizer Inc .; Pharmacia Corporation; Sanofi Pharmaceuticals, Inc . ; SolvayPharmaceuticals, Inc . ; Watson; Wyeth Pharmaceuticals; Yamanouchi; AstraZeneca Pharmaceuticals ;Abbott Laboratories; Aventis; Fabre Kramer; Lorex ; Lundbeck; Neurocrine; NovartisPharmaceuticals Corporation ; Pierre Fabre ; Sanao; Roche ; SumimotoSAMHSA (employer)MRC Unit on Anxiety Disorders (employer)Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc . ; Novartis PharmaceuticalsCorporation; Pfizer Inc . ; GlaxoSmithKline; Solvay Pharmaceuticals, Inc .;Wyeth Pharmaceuticals; Allergan; Alza Pharmaceuticals ; Janssen Pharmaceutica and ResearchFoundation; Hoffman-LaRoche ; Pharmacia Corporation

61Abbott Laboratories ; Pfizer Inc . ; Janssen Pharmaceutica and Research Foundation

14,65Organon Inc .

6Eli Lilly and Company; Solvay Pharmaceuticals, Inc . ; Pfizer Inc .

49Schering-Plough Corp .

55,66Pfizer Inc . ; Novartis Pharmaceuticals Corporation ; Janssen Pharmaceutica and ResearchFoundation

7Abbott Laboratories ; AstraZeneca Pharmaceuticals ; Bristol-Myers Squibb; Eli Lilly and Company;GlaxoSmithKline ; Janssen Pharmaceutica and Research Foundation; Novartis PharmaceuticalsCorporation; Pfizer Inc .; Pharmaceutical Research Institute

8,11Abbott Laboratories ; GlaxoSmithKline; UCB; Bristol-Myers Squibb; Shire U.S ., Inc.; NovartisPharmaceuticals Corporation; Shire U.S ., Inc. ; Robert Wood Johnson .

65,87GlaxoSmithKline; Eli Lilly and Company

3,37AstraZeneca Pharmaceuticals

12AstraZeneca Pharmaceuticals ; Bristol-Myers Squibb ; Eli Lilly and Company ; JanssenPharmaceutica and Research Foundation ; Novartis Pharmaceuticals Corporation; Pfizer Inc.

38, 85, 93AstraZeneca Pharmaceuticals

14Abbott Laboratories; AstraZeneca Pharmaceuticals; Bayer Corporation, Pharmaceutical Division ;Eisai Inc . ; Eli Lilly and Company; Janssen Pharmaceutica and Research Foundation; Lundbeck;Novartis Pharmaceuticals Corporation; Pfizer Inc. ; Sanofi Pharmaceuticals, Inc . Berlex; PharmaciaCorporation; Schwabe

2, 7, 86Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc . ; GlaxoSmithKline; Merck& Co., Inc. ; Organon Inc . ; Pfizer Inc.; Pharmacia Corporation; Wyeth Pharmaceuticals ; Parke-Davis, Division of Warner-Lambert Company; Solvay Pharmaceuticals, Inc .

6, 11, 59, 66Eli Lilly and Company; GlaxoSmithKline; Organon Inc. ; Wyeth Pharmaceuticals; Pfizer Inc.

87Pfizer Inc .

76Eli Lilly and Company (employer)

24,48Professional Risk Management Services, Inc .

18, 42, 72Abbott Laboratories ; Akzo ; Bayer Corporation, Pharmaceutical Division ; Bristol-MyersSquibb; Eli Lilly and Company; Forest Laboratories, Inc .; G1axoSmithKline ; OrganonInc. ; Pharmacia Corporation; Solvay Pharmaceuticals, Inc .; Janssen Pharmaceutica and ResearchFoundation; Johnson and Johnson ; National Institute of Mental Health ; Mead Johnson ; Parke-Davis, Division of Warner-Lambert Company ; Pfizer Inc.; Wyeth Pharmaceuticals

9,60Lilly Research Laboratories, a division of Eli Lilly and Company; Janssen Pharmaceutica andResearch Foundation

52Eli Lilly and Company; GlaxoSmithKline ; Pfizer Inc .; Solvay Pharmaceuticals, Inc . ; Ortho-McNeil

8Janssen Pharmaceutica and Research Foundation; Purdue Pharmaceuticals; Eli Lilly and Company;Nestle

74,91GlaxoSmithKline; Pfizer Inc . ; Eli Lilly and Company ; Wyeth Pharmaceuticals; AstraZenecaPharmaceuticals; Janssen Pharmaceutica and Research Foundation ; Bristol-Myers Squibb

22All India Institute of Medical Sciences (employer)

74Organon Inc. ; Forest Laboratories, Inc . ; Janssen Pharmaceutica and Research Foundation

7Lilly Research Laboratories, a division of Eli Lilly and Company ; Pfizer Inc. ; AbbottLaboratories; GlaxoSmithKline; Searle; Janssen Pharmaceutica and Research Foundation ;Neotherapeutics

6

37,579057

Page 13: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

5

86

579057

61656

4966

7

11

873712

9314

86

6687764872

60

528

91

22747

DISCLOSURE INDEX

Presenter Manufacturer(s) Program Page #

Garry M . Vickar, M.D . Eli Lilly and Company; Johnson and Johnson; Merck & Co., Inc. ; GlaxoSmithKline; Pfizer Inc.;Elan; Wyeth Pharmaceuticals 33

Bruce S . Victor, M .D . Eli Lilly and Company; Pfizer Inc . ; Wyeth Pharmaceuticals ; Bristol-Myers Squibb; AbbottLaboratories 15

Walter V. Vieweg, M.D . Janssen Pharmaceutica and Research Foundation 3Adele C. Viguera, M .D . Wyeth Pharmaceuticals ; Eli Lilly and Company 11,32Joseph R . Volpicelli, M.D. Mallinckrodt, Inc. 83Karen D. Wagner, M.D . GlaxoSmithKline; Pfizer Inc . ; Abbott Laboratories; Lilly Research Laboratories, a division of

Eli Lilly and Company ; Bristol-Myers Squibb ; Organon Inc.; Forest Laboratories, Inc . ; WyethPharmaceuticals; Janssen Pharmaceutica and Research Foundation ; Celexa; Lamictal 3,5

B. Timothy Walsh, M.D. Knoll Pharmaceuticals ; Eli Lilly and Company; Ortho-McNeil Pharmaceuticals 59,86James K. Walsh, Ph.D . Pharmacia Corporation ; Lorex Pharmaceuticals; Searle; Pfizer Inc. ; Abbott Laboratories ;

Amerian Cyanamid; Hoffman-LaRoche; Merck & Co., Inc. ; Bristol-Myers Squibb; WyethPharmaceuticals; Takeda Pharmaceuticals ; Ancile Pharmaceuticals; Neurocrine Biosciences ;Cephalon, Inc . ; Sepracor, Inc .; Whitehall-Robbins; Eli Lilly and Company; SanofiPharmaceuticals, Inc .; CoCensys Pharmaceuticals ; Proctor and Gamble 85

Khakasa H. Wapenyi, M .D . AstraZeneca Pharmaceuticals 29,75Julia K. Warnock, M.D . Pfizer Inc. ; GlaxoSmithKline; Forest Laboratories, Inc . ; Pherin; Solvay Pharmaceuticals, Inc . 65,87Deborah Wasilchak Community Care Behavior Health (employer) 43Peter J . Weiden, M.D . AstraZeneca Pharmaceuticals; Bristol-Myers Squibb ; Janssen Pharmaceutica and Research

Foundation; Lilly Research Laboratories, a division of Eli Lilly and Company ; Pfizer Inc. 9, 86, 92Daniel R. Weinberger, M.D . Lilly Research Laboratories, a division of Eli Lilly and Company ; Janssen Pharmaceutica and

Research Foundation; Bristol-Myers Squibb 6, 12, 86Robert M. Weinrieb, M .D . Dupont Pharma 44Risa B. Weisberg, Ph .D . Pfizer Inc . 22Myrna M. Weissman, Ph .D . GlaxoSmithKlne 3,97Elizabeth B. Weller, M.D. GlaxoSmithKline; Wyeth Pharmaceuticals ; Forest Laboratories, Inc . ; Organon Inc. ; Johnson

and Johnson 97Gary L. Wenk, Ph .D . Forest Laboratories, Inc . 85Joyce C . West, Ph.D . APIRE 60Mark D . Wiederhold, M .D . The Virtual Reality Medical Center ; VR Health; Interactive Media Institute 98Timothy E. Wilens, M.D. Alza Pharmaceuticals ; Abbott Laboratories ; Meckva; Shire U.S ., Inc . ; Lilly

Research Laboratories, a division of Eli Lilly and Company ; GlaxoSmithKline ; National Instituteof Mental Health ; National Institute on Drug Abuse ; Novartis Pharmaceuticals Corporation ;Janssen Pharmaceutica and Research Foundation ; Pfizer Inc . ; NICMI-I 5,47

Denise E . Wilfley, Ph .D . Abbott Laboratories; Ortho-McNeil Pharmaceuticals 86Martin S . Willick, M.D . Bristol-Myers Squibb 6John W. Winkelman, M .D . Eli Lilly and Company; Pfizer Inc. ; Cephalon, Inc . ; Wyeth Pharmaceuticals ; Parke-Davis,

Division of Warner-Lambert Company; Searle 10, 27, 86Donna A. Wirshing, M.D . Lilly Research Laboratories, division EliJanssen Pharmaceutica and Research Foundation;

a

ofLilly and Company; AstraZeneca Pharmaceuticals ; Organon Inc. ; Novartis PharmaceuticalsCorporation; Pfizer Inc. ; PPD Pharmaco 3

Scott W. Woods, M.D. Eli Lilly and Company 95Mary R. Worthen Eli Lilly and Company 11Janet Wozniak, M.D . Alza Pharmaceuticals ; Pharmacia Corporation ; Eli Lilly and Company 3,38Jesse H . Wright, M .D . Mindstreet 18, 26, 30, 66, 78Kevan R. Wylie, M.D . Pfizer; Abbott Laboratories ; Lilly Research Laboratories, a division of Eli Lilly and Company 49Joel Yager, M .D. Eli Lilly and Company 7, 26, 30, 77Rachel Yehuda, Ph.D . GlaxoSmithKline; Pfizer Inc .; Janssen Pharmaceutica and Research Foundation ; Bristol-Myers

Squibb 8,71Kimberly A. Yonkers, M.D. Eli Lilly and Company; GlaxoSmithKline ; Berlex; Pfizer Inc. ; American Home Products;

Wyeth Pharmaceuticals 11,87Stuart Yudofsky, M.D. Bristol-Myers Squibb 13,37John M . Zajecka, M .D. Bristol-Myers Squibb; Eli Lilly and Company; Cephalon, Inc .; Cyberonics; GlaxoSmithKline;

Lichtwer Pharma; MIICRO, Inc . ; Otsuka Pharmaceuticals ; Parke-Davis, Division of Warner-Lambert Company; Pfizer Inc . ; Wyeth Pharmaceuticals; Abbott Laboratories; PharmaciaCorporation 37

Douglas M. Ziedonis, M .D . Janssen Pharmaceutica and Research Foundation ; Lilly Research Laboratories, a division ofEli Lilly and Company; GlaxoSmithKline; Novartis Pharmaceuticals Corporation ; Pfizer Inc. 33

Page 14: PROGRAM - PsychConflicts.org · 2012. 10. 2. · AMERICAN PSYCHIATRIC ASSOCIATION CONTINUING MEDICAL EDUCATION POLICY ON FULL DISCLOSURE The American Psychiatric Association requires

DISCLOSURE INDEX

The following presenters on this year's scientific program failed to return the APA disclosure form.number(s) the presenter appears on in this Program Book are listed below •

Nancy C. Andreasen, M .D .William Arroyo, M .D.Gregory L. BarkerGuido Belsasso, M .D .Eric G . Bing, M.D .Herve Bokobza, M.D .Gary Cobb

82894189945980

Marvis Frazier 80Amarsingh M. Ghorpade, M.D . 48Jodi Goldstein, J.D. 76Norma Hatot 77Ruben J . Hernandez-Serrano, M .D. 84Michael J . Kittay, M.D . 90Louis J . Kraus, M.D .

89

The presenter's name and the page

Earl C. Lawrence, M.A .Alexandra MacLean, M.D .Cesare Maffei, M.D .Farris Tuma, Sc .D .Mike WardWendy WilliamsLishan Workeneh, M .D.

41593171418042


Recommended